SUSTAIN 5 confirmed the efficacy of this regimen, showing that the addition of semaglutide to a stable basal insulin regimen reduced HbA1c levels and body weight relative to placebo, and the associated increase in hypoglycemic episodes did not reach statistical significance [ 48 ].
← all excerpts
Semaglutide in Metabolic Medicine: <i>A Review on Clinical Applications and Emerging Therapeutics</i>.
1
—
—